Enzymatic DNA Synthesis Market to Surge to US$2.11 Billion by 2028 Driven by Advances in Synthetic Biology and Genetic Engineering Technologies – ResearchAndMarkets.com

Enzymatic DNA Synthesis Market to Surge to US$2.11 Billion by 2028 Driven by Advances in Synthetic Biology and Genetic Engineering Technologies – ResearchAndMarkets.com

Enzymatic DNA Synthesis Market to Surge to US$2.11 Billion by 2028 Driven by Advances in Synthetic Biology and Genetic Engineering Technologies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Enzymatic DNA Synthesis Market: Analysis By Product Type (DNA Library Synthesis and Custom DNA Synthesis), By Technology, By Application, By End User, By Region, Size, Trends and Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

The latest industry analysis on the global enzymatic DNA synthesis market projects a robust growth trend as the sector witnesses high demand fueled by breakthroughs in synthetic biology, genetic engineering, and therapeutic applications.

According to the report, the market, which stood at US$253.42 million in 2022, is forecasted to reach US$2.11 billion by 2028, expanding at an impressive compound annual growth rate (CAGR) of 42.43% during the period from 2023 to 2028.

The research provides a detailed segmentation of the market, offering insightful data on various product types, technologies, applications, and end-users. Within the product type realm, the DNA Library Synthesis segment commands a significant share, underscoring its integral role in genomics and proteomics research, while the Custom DNA Synthesis sector also exhibits substantial growth potential.

In terms of technology, Polymerase Chain Reaction (PCR) technology remains a cornerstone, supporting a multitude of applications, from DNA manipulation to molecular diagnostics. Meanwhile, emerging technologies such as CRISPR and cell-free synthetic biology are identified as disruptive trends shaping the market considerably.

The application of enzymatic DNA synthesis in synthetic biology dominates the market, propelled by innovative developments in the fabrication of synthetic genes and organisms. The report elucidates that therapeutic antibodies, genetic engineering, and vaccine design are pivotal applications driving demand in this innovative market.

Regional Insights

Geographically, North America leads the market, showcasing a robust infrastructure and extensive research initiatives. Yet, it is the Asia Pacific region that is forecasted to emerge as the fastest-growing market in the coming years, attributed to increased investments in genomic research, personalized medicine, and burgeoning scientific endeavors across academic and research institutions in the region.

Market Dynamics and Future Growth Engines

  • Rising prevalence of genetic disorders – As the understanding of genetic diseases expands, demand escalates for novel DNA-based diagnostic and therapeutic strategies.
  • Technological advancements – With continuous enhancements in enzymes and synthetic methods, enzymatic DNA synthesis is increasingly capable of delivering high precision and customization.
  • Synthetic biology applications – Adoption of enzymatic synthesis in crafting biological systems fuels the growth of this scientific field, offering potent growth prospects for the market.
  • CRISPR-Cas9 integration – The incorporation of CRISPR-Cas9 in enzymatic DNA synthesis heralds a new era of precision in genetic manipulation, augmenting market expansion.

While the industry navigates challenges such as stringent regulations and complex operational procedures, the continuous innovation and the integration of CRISPR-Cas9 make it primed for overcoming these hurdles effectively.

Competitive Landscape and Key Industry Disruptors

The competitive landscape of the enzymatic DNA synthesis market is characterized by a blend of established players and emerging startups, each contributing novel solutions that redefine DNA synthesis capabilities. This competition is intensified by ongoing efforts in research and development, aimed at creating more sophisticated and efficient enzymes.

Key Players Profiled:

  • Telesis Bio Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corp.
  • Evonetix
  • Ansa Biotechnologies, Inc.
  • Camena Bio
  • Molecular Assemblies
  • DNA Script
  • Touchlight
  • Kern Systems

These industry dynamics reveal a progressive market trajectory, with enzymatic DNA synthesis cementing itself as a cornerstone technology in the biotech landscape and a critical catalyst for future scientific advancements.

Key Attributes:

Report Attribute Details
No. of Pages 157
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $0.25 Billion
Forecasted Market Value (USD) by 2028 $2.11 Billion
Compound Annual Growth Rate 42.4%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/dvq8rd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.



Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900